Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7022-7030

  Biedermann, Barbara C ^a,b   Pober, Jordan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bruderholzspital ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTERY GRAFT; ARTERY INTIMA; ARTICLE; CELL SPECIFICITY; CYTOTOXIC T LYMPHOCYTE; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL DIFFERENTIATION; CELLS, CULTURED; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOPHENOTYPING; ISOANTIGENS; LYMPHOCYTE ACTIVATION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033564639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jutte, N. H., C. J. Knoop, P. Heijse, A. H. Balk, B. Mochtar, F. H. Claas, and W. Weimar. 1996. Human heart endothelial-cell-restricted allorecognition. Transplantation 62:403.
2. Biederman, B. C., and J. S. Pober. 1998. Human endothelial cells induce and regulate cytolytic T cell differentiation. J. Immunol. 161:4679.
3. Epperson, D. E., and J. S. Pober. 1994. Antigen-presenting function of human endothelial cells: direct activation of resting CD8 T cells. J. Immunol. 153:5402.
4. Tosato, G. 1994. Generation of Epstein-Barr-virus (EBV)-immortalized B cell lines. In Current Protocols in Immunology, Vol. 7. J. E. Coligan, A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, pp. 22.1-22.3.
5. Lichtenfels, R., W. E. Biddison, H. Schulz, A. B. Vogt, and R. Martin. 1994. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172:227.
6. Wang, W., S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard. 1998. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160:1091.
7. Van de Griend, R. J., and R. L. Bolhuis. 1984. Rapid expansion of allospecific cytotoxic T cell clones using nonspecific feeder cell lines without further addition of exogenous IL2. Transplantation 38:401.
8. + T cells. J. Exp. Med. 188:103.
9. Seko, Y., S. Ishiyama, T. Nishikawa, T. Kasajima, M. Hiroe, N. Kagawa, K. Osada S. Suzuki, H. Yagita, K. Okumura, et al. 1995. Restricted usage of T cell receptor Vα-Vβ genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J. Clin. Invest. 96:1035.
10. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia. 1993. Expression of two T cell receptor α chains: dual receptor T cells. Science 262:422.
11. Li, J. H., D. Rosen, D. Ronen, C. K. Behrens, P. H. Krammer, W. R. Clark, and G. Berke. 1998. The regulation of CD95 ligand expression and function in CTL. J. Immunol. 161:3943.
12. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
13. Mackey, M. F., R. J. Barth Jr., and R. J. Noelle. 1998. The role od CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol. 63:418.
14. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol. 157:4811.
15. Steinmuller, D., M. E. Snider, R. L. Noble, and T. J. Waldschmidt. 1990. Dissociation of tissue destruction induced by cytolytic T cells in vivo and cytotoxicity as measured in vitro. Transplantation 50:663.
16. Heath, W. R., and L. A. Sherman. 1991. Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur. J. Immunol. 21:153.
17. Hadley, G. A., E. A. Rostapshova, and S. T. Bartlett. 1996. Dominance of tissue-restricted cytotoxic T lymphocytes in the response to allogeneic renal epithelial cell lines. Transplantation 62:75.
18. Warren, E. H., P. D. Greenberg, and S. R. Riddell. 1998. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 91:2197.
19. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
20. + CTL. J. Immunol. 159:3748.
21. + T cells. J. Exp. Med. 186:1407.
22. DiSanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541.
23. Kroczek, R. A., D. Graf, D. Brugnoni, S. Giliani, U. Korthuer, A. Ugazio, G. Senger, H. W. Mages, A. Villa, and L. D. Notarangelo. 1994. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGMI)." Immunol. Rev. 138:39.
24. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
25. + T-helper and a T-killer cell. Nature 393:474.
26. Mach, F., U. Schonbeck, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396.
27. Dechanet, J., C. Grosset, J. L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J. F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J. Immunol. 159:5640.
28. + T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25:2972.
29. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
30. Colvin, R. B., A. H. Cohen, C. Saiontz, S. Bonsib, M. Buick, B. Burke, S. Carter, T. Cavallo, M. Haas, A. Lindblad, et al. 1997. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J. Am. Soc. Nephrol. 8:1930.
31. Labarrere, C. A., D. R. Nelson, and W. P. Faulk. 1997. Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA 278:1169.
32. 1997. Renal transplantation: access and outcomes. USRDS, United States Renal Data System. Am. J. Kidney Dis. 30:S118.
33. Nagano, H., R. N. Mitchell, M. K. Taylor, S. Hasegawa, N. L. Tilney, and P. Libby. 1997. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 100:550.
34. Zheng, X. X., A. D. Schachter, L. Vasconcellos, J. Strehlau, Y. Tian, M. Shapiro, W. Harmon, and T. B. Strom. 1998. Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation 65:1512.
35. Strehlau, J., M. Pavlakis, M. Lipman, W. Maslinski, M. Shapiro, and T. B. Strom. 1996. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin. Nephrol. 46:30.
36. Mach, F., U. Schonbeck, G. K. Sukhova, E. Atkinson, and P. Libby. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200.
37. Hancock, W. W., R. Buelow, M. H. Sayegh, and L. A. Turka. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4:1392.